1. ANALYSIS OF CLINICAL DETERMINANTS DRIVING SAFETY AND EFFICACY OF CAMIDANLUMAB TESIRINE (ADCT‐301, CAMI) IN RELAPSED/REFRACTORY (R/R) CLASSICAL HODGKIN LYMPHOMA (CHL). (12th June 2019) Authors: Collins, G.; Horwitz, S.; Hamadani, M.; Samaniego, F.; Spira, A.; Caimi, P.; Davies, A.; Menne, T.; Fields, P.; Cruz, H.; He, S.; Boni, J.; Feingold, J.; Wuerthner, J.; Radford, J. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 95 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. EXCELLENT OUTCOMES USING RITUXIMAB, GEMCITABINE, CYCLOPHOSPHAMIDE, VINCRISTINE, PREDNISOLONE (R‐GCVP) IN PATIENTS WITH DLBCL AND CARDIAC COMORBIDITIES. (12th June 2019) Authors: Michalarea, V.; Low, R.; Kirkwood, A.A.; Harrington, P.; Yadollahi, S.; Djebbari, F.; Gleeson, M.; Cwynarski, K.; Lambert, J.; Chau, I.; Wrench, D.; Eyre, T.A.; Davies, A.; Ardeshna, K.M.; Cunningham, D.; Fields, P. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 425 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Impact of intended and relative dose intensity of R‐CHOP in a large, consecutive cohort of elderly diffuse large B‐cell lymphoma patients treated with curative intent: no difference in cumulative incidence of relapse comparing patients by age. (11th April 2019) Authors: Eyre, T. A.; Martinez‐Calle, N.; Hildyard, C.; Eyre, D. W.; Plaschkes, H.; Griffith, J.; Wolf, J.; Fields, P.; Gunawan, A.; Oliver, R.; Djebbari, F.; Booth, S.; McMillan, A.; Fox, C. P.; Bishton, M. J.; Collins, G. P.; Hatton, C. S. R. Journal: Journal of internal medicine Issue: Volume 285:Number 6(2019) Page Start: 681 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗